ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.

Conditions

• The Primary Study Objective is to Assess the Efficacy and
• Safety of Extended 4-week Heparin Prophylaxis Compared to
• Prophylaxis Given for 8±2 Days After Planned Laparoscopic
• Surgery for Colorectal Cancer.
• The Clinical Benefit Will be Evaluated as the Difference in
• the Incidence of VTE or VTE-related Death Occurring Within 30 Days
• From Surgery in the Two Study Groups.

Interventions

• DRUG: Heparin, Low-Molecular-Weight

Sponsor

University Of Perugia